Treatment.Com International Inc. (TRUE.CN)
CAD 0.55
(5.77%)
CAD 0.55
(5.77%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 442.13 Thousand CAD | -21.92% |
| 2022 | 566.27 Thousand CAD | 0.0% |
| 2021 | - CAD | 0.0% |
| 2020 | - CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 100.33 Thousand CAD | -78.25% |
| 2024 Q1 | 461.21 Thousand CAD | 4.32% |
| 2023 Q4 | 442.13 Thousand CAD | -27.42% |
| 2023 Q3 | 609.17 Thousand CAD | -11.2% |
| 2023 Q2 | 686.01 Thousand CAD | 8.28% |
| 2023 Q1 | 633.56 Thousand CAD | 11.88% |
| 2023 FY | 442.13 Thousand CAD | -21.92% |
| 2022 Q4 | 566.27 Thousand CAD | 12.73% |
| 2022 Q2 | 328.65 Thousand CAD | 78.6% |
| 2022 Q1 | 184.01 Thousand CAD | 0.0% |
| 2022 FY | 566.27 Thousand CAD | 0.0% |
| 2022 Q3 | 502.34 Thousand CAD | 52.85% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 FY | - CAD | 0.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 FY | - CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AI/ML Innovations Inc. | 197.72 Thousand CAD | -123.617% |
| Diagnamed Holdings Corp. | - CAD | -Infinity% |
| Pangenomic Health Inc. | 964.74 Thousand CAD | 54.171% |
| nDatalyze Corp. | - CAD | -Infinity% |
| Unidoc Health Corp. | 74.85 Thousand CAD | -490.655% |